Anticancer Drugs Course
This course equips oncology pros with practical skills for EGFR-mutant NSCLC treatment. Master first-line EGFR TKI choices, toxicity management, resistance strategies, monitoring, and patient talks. Gain tools for better outcomes and clear communication using evidence-based approaches.

from 4 to 360h flexible workload
valid certificate in your country
What will I learn?
Explore first-line treatments for EGFR-mutated NSCLC: targeted therapies, chemo-immunotherapy, chemotherapy. Cover drug actions, dosing, toxicities, prevention, resistance, second-line choices, monitoring, and communication for solid decisions.
Elevify advantages
Develop skills
- Select EGFR TKIs using latest trial data for first-line treatment.
- Plan resistance tests like imaging, biopsies to direct next therapies.
- Match resistance to targeted drugs, chemo, or trials for second-line.
- Prevent and handle EGFR TKI side effects like rash, diarrhea, ILD.
- Counsel patients clearly on treatment goals, effects, and next steps.
Suggested summary
Before starting, you can change the chapters and workload. Choose which chapter to start with. Add or remove chapters. Increase or decrease the course workload.What our students say
FAQs
Who is Elevify? How does it work?
Do the courses have certificates?
Are the courses free?
What is the course workload?
What are the courses like?
How do the courses work?
What is the duration of the courses?
What is the cost or price of the courses?
What is an online course and how does it work?
PDF Course